Conferences
#ESHLYMPHOID2021

6th Translational Research Conference
Lymphoid Malignancies

‍

#ESHLYMPHOID2021
Translational
October 14-17, 2021
-
E-Conference

Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt

Advisory Board: Barbara Eichhorst, Ricardo Dalla-Favera , Frank Morschhauser, Laura Pasqualucci, Stephan Stilgenbauer, Andrei Thomas-Tikhonenko

‍

6th Translational Research Conference
Lymphoid Malignancies

‍

Information

‍

ABOUT THE CONFERENCE:

ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives.
The presentation of unpublished data is encouraged.

This leading-edge translational research conference will address the rapidly evolving field of  lymphoid malignancies, including T- and B-cell lymphomas, and chronic lymphocytic leukaemia (CLL), from molecular pathogenesis to state-of-the-art treatment and future perspectives.  
The goals of this conference are to:
– foster scientific exchange between laboratory scientists and clinicians working on lymphoid malignancies worldwide,
– foster scientific cross-fertilization between researchers and clinicians working on different diseases with partially overlapping pathogenic mechanisms such as the B cell receptor signaling, alterations of the DNA damage response, or the increasingly important dialogue of lymphoid tumour cells with their microenvironment,
– provide opportunities for leading-edge education and international networking to basic and clinical scientists, including those still in-training.

A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of Lymphoid Malignancies.

‍

SCIENTIFIC TOPICS:

• B-cell development and lymphomagenesis
• Genetics of malignant lymphomas and clonal evolution
• Epigenetics in malignant lymphomas
• Deregulated proteome and metabolome
• Single cell analyses, circulating tumor DNA, MRD
• Oncogenic signaling pathways
• Utilizing oncogenic signaling therapeutically
• Immunologic approaches in the treatment of lymphomas

Programme

Read the final programme!

CLICK HERE
ON-DEMAND CONTENT AVAILABLE
CLICK HERE

Corporate partners

With the support of*:

‍

‍Premium E-Conference Partners
*******

‍

‍

Diamond E-Conference Partners
*******

‍

‍

‍Emerald E-Conference Partner
*******

‍

‍

Emerald E-Conference Partner
*******

‍

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

Advancing haematology through international leading-edge disease- focused conferences.

Explore a portfolio of leading-edge scientific, translational research and clinically oriented meetings, designed to foster scientific exchange, practical insight, education and collaboration across clinical and research fields.
Explore all conferences